Synonyms: Emflaza® | MDL 458
deflazacort is an approved drug (UK (1994), FDA (2017))
Compound class:
Synthetic organic
Comment: Deflazacort is a prednisolone derivative glucocorticoid that is used as an anti-inflammatory and immunosuppressant. It is a prodrug that is metabolised to the active form, 21-desacetyl deflazacort (PubChem CID 97547130) [3].
View more information in the IUPHAR Pharmacology Education Project: deflazacort |
|
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Rheumatoid arthritis |
Disease Ontology:
DOID:7148 OMIM: 180300 |
Approved corticosteroid that can be prescribed for RA. | |
Crohn's disease |
Disease Ontology:
DOID:8778 OMIM: 266600 Orphanet: ORPHA206 |
Approved corticosteroid that can be prescribed for CD. | |
Systemic lupus erythematosus |
Disease Ontology:
DOID:9074 OMIM: 152700 Orphanet: ORPHA536 |
Approved corticosteroid that can be prescribed for SLE. | |
Ulcerative colitis |
Disease Ontology:
DOID:8577 OMIM: 266600 Orphanet: ORPHA771 |
Approved corticosteroid that can be prescribed for UC. | |
Juvenile idiopathic arthritis- systemic |
OMIM:
604302 |
Approved corticosteroid that can be prescribed for sJIA. | |
Sarcoidosis |
Disease Ontology:
DOID:11335 |
Approved corticosteroid that can be prescribed for sarcoidosis. | |
Duchenne muscular dystrophy |
Disease Ontology:
DOID:11723 OMIM: 19518854 |
Deflazacort was approved by the US FDA in 2017 as a treatment for DMD. | |
Autoimmune thrombocytopenic purpura |
Disease Ontology:
DOID:8924 OMIM: 188030 Orphanet: ORPHA3002 |
Approved corticosteroid that can be prescribed for ATP. |